• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Advanced Human Imaging Signs Letter of Intent to Acquire Israeli-Based Physimax Technologies

Share:

April 28, 2021

Advanced Human Imaging Limited (ASX: AHI) (“AHI” or the “Company”) is pleased to announce that it has signed a Letter of Intent (LOI) for the proposed acquisition of Israeli-based musculoskeletal assessment company Physimax Technologies Limited (Physimax).

Physimax has developed a revolutionary video-based solution that tracks and improves musculoskeletal wellness, therapy and performance by objective, data-driven analysis of musculoskeletal condition via a mobile device.

The imaging technology measures and scores mobility, stability, strength, and movement control through movement patterns and multidimensional computer analysis. The software-based technology provides a data-driven assessment of an individual’s musculoskeletal system and identifies problematic issues prior to delivering a personalized solution.

“The Physimax team has spent 7 years developing, validating and commercializing this innovative technology that is being applied worldwide with over 250,000 scans performed to date,” said Vlado Bosanac, Chief Executive Officer of AHI. “The technology is being used in multiple facets of musculoskeletal care and enhancement throughout the US, Europe and Asia.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

With no set-up required, the patented technology takes minutes to obtain a professional assessment, with real-time feedback that cuts out the need for an in-person assessment. The substantial time saved for staff and athletes has driven NFL, NBA, MLB and elite soccer teams, D1 colleges, US Military units and top healthcare providers to implement Physimax’s technology to reduce injury and expenses.

This unique system has benefits to cut substantial costs and risks for functional disability. It performs assessments and corrective programs prior to costly surgeries.

Vlado Bosanac continued, “with the on device 2D/3D capturing capabilities of the AHI patented system, we will be working together to provide a best-in-class system with innovative capabilities to the global community. We will continue to identify opportunities that are complementary to the AHI offering, with the intent to either partner, or when advantageous, acquire.”

Musculoskeletal conditions comprise of more than 150 conditions that affect the locomotor system, including fractures, sprains, and strains, to lifelong conditions that can be disabling, persistently painful, and can limit mobility, dexterity and functionality. A recent analysis of Global Burden of Disease data showed that approximately 1.71 billion people globally have musculoskeletal conditions.

The LOI is subject to AHI conducting due diligence to its satisfaction on or before May 21, 2021.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Microsoft, Blue Shield of California Partner for Integrated Data HubMicrosoft, Blue Shield of California Partner for Integrated Data Hub
  • Supriya Lifescience Targets Rs 1,600 Crore RevenueSupriya Lifescience Targets Rs 1,600 Crore Revenue
  • Digital Therapeutics and Their Impact on HealthcareDigital Therapeutics and Their Impact on Healthcare
  • S3 Connected Health Deploy COVID-19 Clinical Support Tool in Irish Health ServiceS3 Connected Health Deploy COVID-19 Clinical Support Tool in Irish Health Service
  • Exscientia Secures $100M To Expand AI Drug Discovery PlatformExscientia Secures $100M To Expand AI Drug Discovery Platform
  • Enochian Biosciences Expands Its Infectious Disease Pipeline By Entering Into An Agreement in Principle to Acquire An Exclusive License for a Novel Hepatitis B Virus TreatmentEnochian Biosciences Expands Its Infectious Disease Pipeline By Entering Into An Agreement in Principle to Acquire An Exclusive License for a Novel Hepatitis B Virus Treatment
  • PointClickCare acquires QuickMAR, expanding offerings for seniors and LTPACPointClickCare acquires QuickMAR, expanding offerings for seniors and LTPAC
  • Effepharm Announced Acquisitions and New R&D Center EstablishmentEffepharm Announced Acquisitions and New R&D Center Establishment

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications